Paradoxical expression of IL-28B mRNA in peripheral blood in human T-cell leukemia virus Type-1 mono-infection and co-infection with hepatitis C Virus

[1]  R. Bartenschlager,et al.  Comparative Analysis of the Lambda-Interferons IL-28A and IL-29 regarding Their Transcriptome and Their Antiviral Properties against Hepatitis C Virus , 2010, PloS one.

[2]  C. Thio,et al.  IL28B and the control of hepatitis C virus infection. , 2010, Gastroenterology.

[3]  K. Shianna,et al.  A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. , 2010, Gastroenterology.

[4]  David B. Goldstein,et al.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.

[5]  Thomas Berg,et al.  IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy , 2009, Nature Genetics.

[6]  A. Koike,et al.  Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C , 2009, Nature Genetics.

[7]  Jacques Fellay,et al.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.

[8]  S. Su,et al.  Interferon- s: the modulators of antivirus, antitumor, and immune responses , 2009 .

[9]  Yasuaki Yamada,et al.  Aberrant p53 protein expression and function in a panel of hematopoietic cell lines with different p53 mutations , 2009, European journal of haematology.

[10]  O. Martínez-Maza,et al.  Population differences in immune marker profiles associated with human T‐lymphotropic virus type I infection in Japan and Jamaica , 2009, International journal of cancer.

[11]  Yasuaki Yamada,et al.  Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells , 2008, Retrovirology.

[12]  S. Kashiwagi,et al.  Antibody to the human T-lymphotropic virus type 1 (HTLV-1) envelope protein Gp46 in patients co-infected with HCV and HTLV-1. , 2007, The American journal of tropical medicine and hygiene.

[13]  F. Mennechet,et al.  Interferon-λ-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells , 2006 .

[14]  S. Paludan,et al.  Lambda Interferon (IFN-λ), a Type III IFN, Is Induced by Viruses and IFNs and Displays Potent Antiviral Activity against Select Virus Infections In Vivo , 2006, Journal of Virology.

[15]  J. Hiscott,et al.  Gene Expression and Antiviral Activity of Alpha/Beta Interferons and Interleukin-29 in Virus-Infected Human Myeloid Dendritic Cells , 2005, Journal of Virology.

[16]  M. Tomonaga,et al.  Possible origin of adult T‐cell leukemia/lymphoma cells from human T lymphotropic virus type‐1‐infected regulatory T cells , 2005, Cancer science.

[17]  S. Kashiwagi,et al.  Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance. , 2001, The Journal of infectious diseases.

[18]  A. Lewis-Antes,et al.  IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. , 2003, Nature immunology.

[19]  D. Trichopoulos,et al.  A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan. , 2000, The Journal of infectious diseases.

[20]  M. Tomonaga,et al.  Human T-lymphotropic virus type-I influence on hepatotropic virus infections and the subsequent development of hepatocellular carcinoma. , 1994, Cancer Detection and Prevention.